Determination of aspirin and salicylic acid in transdermal perfusates.
A high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of aspirin and salicylic acid in transdermal perfusates. The compounds were separated on a C8 Nucleosil column (5 microm, 250x4.6 mm) using a mobile phase containing a mixture of water-acetonitrile-orthophosphoric acid (650:350:2, v/v/v) and a flow-rate of 1 ml/min. The transdermal samples were in phosphate-buffered saline (PBS) and could be injected directly onto the HPLC system. The method was reproducible with inter-day R.S.D. values of no greater than 3.46 and 2.60% for aspirin and salicylic acid, respectively. The method was linear over the concentration range 0.2-5.0 microg/ml and had a limit of detection of 0.05 microg/ml for both compounds. For certain samples, it was necessary to ensure that no transmembrane leakage of the aspirin prodrugs had occurred. In these cases, a gradient was introduced by increasing the acetonitrile content of the mobile phase after the salicylic acid had eluted. The method has been applied to the determination of aspirin and salicylic acid in PBS following in vitro application of the compounds to mouse skin samples.
McMahon
G P
GP
Department of Chemistry, The Royal College of Surgeons in Ireland, St. Stephen's Green, Dublin.
O'Connor
S J
SJ
Fitzgerald
D J
DJ
le Roy
S
S
Kelly
M T
MT
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000032:analysis*; D001241:Aspirin / Q000032:analysis*; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D007202:Indicators and Reagents; D051379:Mice; D012015:Reference Standards; D015203:Reproducibility of Results; D012459:Salicylates / Q000032:analysis*; D020156:Salicylic Acid; D012867:Skin / Q000737:chemistry*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007202:Indicators and Reagents; D012459:Salicylates; D020156:Salicylic Acid; D001241:Aspirin